CCL13 and early-onset autosomal dominant Alzheimer disease: CCL13, an inflammation‐linked chemokine, has been observed to be elevated in the plasma of individuals suffering from aging‐related cognitive impairment, and it demonstrates moderate diagnostic efficacy in Alzheimer's disease (ad) [29].